IL1A and breast carcinoma: In vivo, inhibition of IL-1β signaling with either a mouse anti-IL-1ß -antibody (2 mg/kg) or the human anti-IL-1β antibody anakinra (1 mg/kg/day) reduced breast cancer bone colonization in hind limbs of mice [58].